|
|
Article: Tryton Medical, Inc. Closes $14 Million Financing.
- Article from:
- PR Newswire
- Article date:
- March 31, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEWTON, Mass., March 31 /PRNewswire/ -- Tryton Medical, Inc., the leading developer of stents designed for the definitive treatment of bifurcation lesions announced today that it has closed a $14 million Series C round of financing. Two new investors, PTV Sciences and RiverVest Venture Partners joined with Spray Venture Partners in the financing. Rick Anderson from PTV and Jay Schmelter from RiverVest have been appointed to the Tryton Board of Directors.
"Bifurcation lesions are an important opportunity in the stent marketplace. We have reviewed all the technology approaches in development. The ease-of-use, superb clinical results, and commercialization ...